Invest in Israel Newsletter December 2010 Edition
VC Cafe
DECEMBER 28, 2010
Placement on the list was determined by a combination of the company’s G/SCORE assessment, stage and pace of growth, and business potential. In the Framework of the EC-Funded Invest in Med program, EyalGPS was one of three finalists to be awarded €90,000. From 1999 to 2009, Teva’s revenue grew to about $14 billion from $1.3
Let's personalize your content